Income Taxes (Tables)

12 Months Ended

Jan. 31, 2024

Schedule of Loss before Income Tax, Domestic and Foreign

The Company’s net loss before income tax benefit / (expense) from income taxes includes the following components:


	Year Ended January 31,
	2024		2023		2022
Domestic	$	(114.0)	$	(139.5)	$	(212.6)
Foreign	1.0		0.6		0.5
Net loss before income tax benefit / (expense)	$	(113.0)	$	(138.9)	$	(212.1)

Schedule of Allocation of Income Tax

Total income taxes allocated to operations are as follows:


	Year Ended January 31,
	2024		2023		2022
Current provision:
Federal	$	—	$	—	$	—
State and local	—		—		—
Foreign	(0.2)		—		—
Total current provision	(0.2)		—		—
Deferred provision:
Federal	—		—		—
State and local	—		—		—
Foreign	—		0.2		0.3
Total deferred provision	—		0.2		0.3
Total income tax benefit / (expense)	$	(0.2)	$	0.2	$	0.3

Schedule of Deferred Tax Assets (Liabilities)

The significant components of the Company’s net deferred tax assets (liabilities) are as follows:


	Year Ended January 31,
	2024		2023
Deferred tax assets:
Federal and state net operating loss carryforwards	$	166.4	$	158.1
Customer credit liabilities	1.7		1.9
Interest limitation	58.0		50.0
Fixed assets	2.1		—
Capitalized R&D expenses	14.5		10.1
Tax credits	6.7		5.7
Share-based compensation	1.6		2.4
Operating lease liabilities	13.2		11.8
Other	1.3		0.7
Total deferred tax assets	265.5		240.7
Deferred tax liabilities:
Fixed assets	—		(0.1)
Operating lease right-of-use assets	(9.4)		(7.6)
Total deferred tax liabilities	(9.4)		(7.7)
Net deferred tax assets before valuation allowance	256.1		233.0
Less valuation allowance	(256.1)		(232.4)
Net deferred tax assets	$	—	$	0.6

Schedule of Effective Income Tax Rate Reconciliation

The benefit for income taxes differs from the amount computed by applying the statutory U.S. Federal income tax rate to pretax loss because of the effect of the following items:


	Year Ended January 31,
	2024		2023		2022
Compute “expected” tax benefit	21.00	%	21.00	%	21.00	%
State income taxes, net of federal benefit	(0.02)	%	(0.01)	%	(0.01)	%
Valuation of warrants	—	%	—	%	(2.47)	%
Nondeductible transaction costs	—	%	—	%	(0.44)	%
Nondeductible compensation	(2.55)	%	(1.95)	%	(1.17)	%
Share-based compensation	(0.09)	%	(0.48)	%	(0.35)	%
Current year change in valuation allowance	(19.74)	%	(19.34)	%	(16.90)	%
Other	1.26	%	1.00	%	0.48	%
Income tax benefit (expense)	(0.14)	%	0.22	%	0.14	%

Schedule of Unrecognized Tax Benefits

The following table summarizes the unrecognized tax benefit activity for the periods indicated:


	Year Ended January 31,
	2024		2023		2022
Balance as of the beginning of the period	$	0.9	$	0.7	$	0.6
Additions based on tax positions related to the current year	0.3		0.2		0.1
Additions for tax positions of prior years	—		—		—
Reductions for tax positions of prior years	—		—		—
Lapse of statute of limitations	—		—		—
Settlements	—		—		—
Balance as of the end of the period	$	1.2	$	0.9	$	0.7